Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
US9993460B2 · kind B2 · utility
3Cited by
231References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2014 |
| Grant date | Jun 12, 2018 |
| Priority date | — |
| Expiry date | Jul 25, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutic agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to bisantrene or derivatives, analogs, or prodrugs thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.